Risk factor analysis in differentiated thyroid cancer.

Area of Science:

• Endocrinology
• Oncology
• Epidemiology

Background:

• Differentiated thyroid carcinoma (DTC) prognosis varies significantly among patients.
• Identifying reliable prognostic factors is crucial for effective patient management and treatment stratification.

Purpose of the Study:

• To evaluate the long-term impact of age and sex-based risk stratification on recurrence and mortality in differentiated thyroid carcinoma.
• To determine if basic risk group definitions are more influential than other clinicopathological factors.

Main Methods:

• Longitudinal follow-up study of 600 patients with primary differentiated thyroid carcinoma.
• Minimum follow-up duration of 15 years, maximum of 45 years.
• Risk groups defined by age (men ≤40, women ≤50 for low-risk) and sex.

Main Results:

• Significantly lower recurrence (11% vs. 33%) and death (4% vs. 27%) rates in low-risk versus high-risk groups.
• Age and sex stratification proved more impactful than pathologic type, disease extent, or treatment.
• Radioactive iodine efficacy differed markedly: 70% cure in low-risk metastatic disease vs. 10% in high-risk.

Conclusions:

• Age and sex are powerful independent predictors of differentiated thyroid carcinoma outcomes.
• Estrogen's potential role in modulating thyroid cancer progression warrants further investigation.
• Estrogen-based therapies may be beneficial for progressive metastatic differentiated thyroid cancer.